Search

Your search keyword '"Amanda, Mocroft"' showing total 185 results

Search Constraints

Start Over You searched for: Author "Amanda, Mocroft" Remove constraint Author: "Amanda, Mocroft" Topic humans Remove constraint Topic: humans
185 results on '"Amanda, Mocroft"'

Search Results

1. Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV

2. Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens

Catalog

Books, media, physical & digital resources

3. Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV

4. The role of HIV/hepatitis B virus/hepatitis C virus RNA+ triple infection in end-stage liver disease and all-cause mortality in Europe

5. Mortality and cause of death in persons with chronic hepatitis B virus infection versus healthy persons from the general population in Denmark

6. Switch to INSTIs, but Not Long-Term Stable INSTIs, Is Associated With Excess Weight Gain in People Living With HIV

7. Prevalence and outcomes of pregnancies in women with HIV over a 20-year period

8. Prevalence and Risk Factors of Moderate-to-Severe Hepatic Steatosis in Human Immunodeficiency Virus Infection: The Copenhagen Co-morbidity Liver Study

9. Mortality and admission to intensive care units after febrile neutropenia in patients with cancer

10. Hypersensitivity reactions, hepatotoxicity, and other discontinuations in persons receiving integrase strand transfer inhibitors: results from the EuroSIDA study

11. The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences

12. Long-lasting alterations in adipose tissue density and adiponectin production in people living with HIV after thymidine analogues exposure

13. Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next steps

14. Independent Associations of Tumor Necrosis Factor-Alpha and Interleukin-1 Beta With Radiographic Emphysema in People Living With HIV

15. Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States

16. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

17. Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus

18. A new health care index predicts short term mortality for TB and HIV co-infected people

19. Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral-naïve persons starting treatment

20. Influence of hepatitis C virus co-infection and hepatitis C virus treatment on risk of chronic kidney disease in HIV-positive persons

21. Independent Association of Interleukin 6 With Low Dynamic Lung Function and Airflow Limitation in Well-Treated People With Human Immunodeficiency Virus

22. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

23. Diagnostic performance of clinical characteristics to detect airflow limitation in people living with HIV and in uninfected controls

24. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients

25. Cascade of care and factors associated with virological suppression among HIV-positive persons linked to care in the Test and Keep in Care (TAK) project

26. Contemporary protease inhibitors and cardiovascular risk

27. Where is the greatest impact of uncontrolled HIV infection on AIDS and non-AIDS events in HIV?

28. Airflow limitation in people living with HIV and matched uninfected controls

29. Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma

30. Uptake of Tenofovir-Based Antiretroviral Therapy among HIV–HBV-Coinfected Patients in the EuroSIDA Study

31. Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium

32. Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study

33. Impact of Age and HIV Status on Immune Activation, Senescence and Apoptosis

34. 'Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation'

35. Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study

36. Serious clinical events in HIV-positive persons with chronic kidney disease

37. Prevalence and risk factors of prolonged QT interval and electrocardiographic abnormalities in persons living with HIV

38. Abdominal Adipose Tissue Is Associated With Alterations in Tryptophan-Kynurenine Metabolism and Markers of Systemic Inflammation in People With Human Immunodeficiency Virus

39. Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment

40. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year

41. Prevalence of impaired renal function in virologically suppressed people living with HIV compared with controls:the Copenhagen Comorbidity in HIV Infection (COCOMO) study*

42. Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors

43. Variation in antiretroviral treatment coverage and virological suppression among three HIV key populations

44. Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: The

45. Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial results

46. Brief Report: Prevalence of Peripheral Artery Disease Is Higher in Persons Living With HIV Compared With Uninfected Controls

47. Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

48. Body Mass Index and The Risk of Serious Non-Aids Events and All Cause Mortality in Treated Hiv-Positive Individuals: D: A: D Cohort Analysis

49. Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study

50. European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome Statements